Individualized Nutritional Counselling During Chemotherapy for Colorectal Cancer (COLONUT)
COLONUT
The Effect of Individualized NUTritional Counselling on Muscle Mass and Treatment Outcome in Patients With Metastatic COLOrectal Cancer Undergoing Chemotherapy: the COLONUT Study
1 other identifier
interventional
107
1 country
5
Brief Summary
The purpose is to study the effect of individualized nutritional counselling compared to usual nutritional care on cross-sectional muscle area in patients with stage IV colorectal cancer during first line chemotherapy. Secondary, effect on total lean body mass, treatment intensity, physical functioning, quality of life and survival will be studied.We hypothesize that patients in the intervention arm benefit from individualized nutritional counseling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2013
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 11, 2013
CompletedFirst Posted
Study publicly available on registry
November 28, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2018
CompletedDecember 21, 2018
December 1, 2018
5.1 years
November 11, 2013
December 20, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Change in skeletal muscle area (cm2) between individualized nutritional counselling versus usual nutritional care
will be measured with SliceOmatic software V5.0 (Tomovision) with use of routinely conducted CT scans for diagnostic and disease evaluation purposes
During 9 weeks of first line chemotherapy
Secondary Outcomes (4)
Change in total body lean body mass and segmental lean body mass (DEXA) in patients with stage IV colorectal cancer during 9 weeks of first line chemotherapy between individualized nutritional counseling versus usual nutritional care
During 9 weeks of first line chemotherapy
Change in skeletal muscle area in patients with stage IV colorectal cancer during 20 weeks of first line chemotherapy between individualized nutritional counseling.versus usual nutritional care.
During 20 weeks of first line chemotherapy
Composite of treatment toxicity, treatment intensity, treatment outcome, survival, physical functioning, quality of life and hand grip strength of both study arms
During 9 weeks and during 20 weeks of first line chemotherapy
Associations of (changes in) muscle area with (changes in) mid-upper arm muscle circumference, whole body fat free mass (BIA) and whole body lean body mass (DEXA).
During 9 weeks of first line chemotherapy
Study Arms (2)
Nutritional counseling
EXPERIMENTALIndividualized nutritional counselling by a registered dietitian
No intervention
NO INTERVENTIONUsual nutritional care by the oncologist. A dietitian is only involved when serious nutritional problems occur.
Interventions
Patients in the intervention-arm will receive individualized nutritional counseling by a registered dietitian during standard treatment with chemotherapy. The main goals of the nutritional intervention will be to enable every patient to achieve sufficient protein and energy intake with attention for sufficient intake of micronutrients and a sufficient physical activity level.
Eligibility Criteria
You may qualify if:
- Age ≥18 years
- Stage IV colorectal cancer
- Scheduled for treatment with first line chemotherapy, either CAPOX(-B), FOLFOX(-B) or capecitabine(-B)
- CT scan suitable for evaluating muscle mass at L3 level
- Understanding of the Dutch language
- Able and willing to give written informed consent
You may not qualify if:
- Chemotherapy in the previous three months
- WHO performance status ≥ 3
- Long-term high dose of corticosteroids: ≥ three weeks ≥ ten milligram prednisolon or equivalent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
VU Medical Center
Amsterdam, NL-1081 HV, Netherlands
Amphia Hospital
Breda, 4819 EV, Netherlands
Reinier de Graaf
Delft, 2625 AD, Netherlands
Ziekenhuis Gelderse Vallei
Ede, 6716 RP, Netherlands
Spaarne hospital
Hoofddorp, NL-2134 TM, Netherlands
Related Publications (2)
van der Werf A, Langius JAE, Beeker A, Ten Tije AJ, Vulink AJ, Haringhuizen A, Berkhof J, van der Vliet HJ, Verheul HMW, de van der Schueren MAE. The effect of nutritional counseling on muscle mass and treatment outcome in patients with metastatic colorectal cancer undergoing chemotherapy: A randomized controlled trial. Clin Nutr. 2020 Oct;39(10):3005-3013. doi: 10.1016/j.clnu.2020.01.009. Epub 2020 Jan 29.
PMID: 32037284DERIVEDvan der Werf A, Blauwhoff-Buskermolen S, Langius JA, Berkhof J, Verheul HM, de van der Schueren MA. The effect of individualized nutritional counseling on muscle mass and treatment outcome in patients with metastatic colorectal cancer undergoing chemotherapy: a randomized controlled trial protocol. BMC Cancer. 2015 Mar 5;15:98. doi: 10.1186/s12885-015-1092-5.
PMID: 25884881DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
M.A.E de van der Schueren, Dr.
Amsterdam UMC, location VUmc
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Investigator dietetics and nutrition sciences Vumc
Study Record Dates
First Submitted
November 11, 2013
First Posted
November 28, 2013
Study Start
November 1, 2013
Primary Completion
December 1, 2018
Study Completion
December 15, 2018
Last Updated
December 21, 2018
Record last verified: 2018-12